戻る Agenda
Artificial Intelligence Validation Framework: Is it New and Different?
Session Chair(s)
Kristof Huysentruyt, MSc
Leadinbg the development solutions business transformation initiative
UCB Pharma S.A., Belgium
How will artificial intelligence and machine learning align with the validation documentation to affirm compliance. What are risk-based approaches? What are the challenges of validating machine learning and artificial intelligence?
Learning Objective : Recognize the definitions of artificial intelligence; Explain and apply the risk-based framework that applies to artificial intelligence; Describe challenges and potential approaches for affirming compliance.
Speaker(s)
Industry Update
Kristof Huysentruyt, MSc
UCB Pharma S.A., Belgium
Leadinbg the development solutions business transformation initiative
Industry Update
Oeystein Kjoersvik, MS, MSc
Merck Sharp & Dohme LLC, Czech Republic
Technology Auditor and Quality Projects Lead
Industry Update
Elizabeth Anne MacEntee Pileggi, BSN, MBA
Johnson & Johnson, United States
Senior Director, Head of Global Case and Safety Data Management